相关实验视频

Updated: Jun 21, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

阿特佐利祖马布加贝瓦齐祖马布作为肝细胞癌的第一线全身治疗:一个多机构队列研究

Michael H Storandt¹, Tyler J Zemla², Kanchi Patell³

¹Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.

|July 9, 2024

概括

阿特佐利祖马布加贝瓦齐祖马布在晚期肝细胞癌 (HCC) 中显示有好处,但结果因儿童普格 (CP) 评分和ALBI等级而异. 该疗法对CP-B7患者是可行的,尽管与CP-A相比,它的疗效降低了.

科学领域:

肝细胞癌研究肝细胞癌研究
癌症免疫疗法癌症免疫疗法
临床结果研究研究

背景情况:

阿特佐利祖马布加贝瓦齐祖马布是高级HCC的标准一线护理.
IMbrave150试验数据主要包括Child-Pugh (CP) A患者.
基于CP得分和ALBI等级的现实世界结果在美国人口中还没有得到很好的定义.

研究的目的:

为了评估先进的HCC患者的结果,他们接受了阿特佐利祖马布加贝瓦西祖马布的治疗.
评估Child-Pugh (CP) 评分和ALBI等级对患者存活时间的影响.
为了确定这种治疗方案在肝功能不同患者中的可行性和安全性.

主要方法:

在322名接受阿特佐利祖马布加贝瓦西祖马布治疗的HCC患者中进行了多中心队列研究.
在2018年3月至2023年11月之间进行的一线全身疗法.
使用卡普兰-梅尔和考克斯回归分析的整体存活率 (OS).

主要成果:

平均生存期为21.6个月 (CP-A),9.1个月 (CP-B7) 和4.7个月 (CP-B8-C12).
在CP-A患者中,ALBI级1的mOS比2级 (14.2个月) 长 (34.9个月).
脑膜炎得分,ALBI等级,乙型肝炎,表现状况和大血管侵入是显著的预后因素.

结论:

在接受阿特佐利祖马布/贝瓦西祖马布治疗的高级HCC患者中,CP得分是关键的预后指标.
这种疗法对CP-B7患者来说是一个可行的选择,其益处减少了,但目前仍然存在.
ALBI评分独立预测了CP-A患者的结果.

关键词:

阿尔比阿尔比是什么意思孩子们的Pugh-Pugh.它们是Atezolizumab.这是bevacizumab的治疗方法.肝细胞癌是肝细胞癌.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...